Intelligent Medical Devices, Inc.

Alice A Jacobs

Vineet Gupta

Boris Nikolic

Chesley Leslin

David Dolinger

Damien Slater

Heather L B Kiefer

Juan Manuel Anzola

Juan Anzola

James R Hully

The invention relates to the clinically intelligent design of diagnostic devices (such as microarrays) and methods of making and using such devices in differential diagnoses of specific clinical symptoms or sets of symptoms. In one aspect, the devices include various probes used to perform parallel screening of a number of analytes. The probes are clustered on the devices based on known clinical presentations of symptoms associated with specific diseases and disorders.

Clinically intelligent diagnostic methods utilizing micromixers disposed in wells

Described herein are oligonucleotides useful for detecting, isolating, amplifying, quantitating, monitoring, screening and sequencing GBS genes and methods of using the described oligonucleotides.

[object Object]

Described herein are primers and probes useful for the binding, detecting, differentiating, isolating, and sequencing of influenza A, influenza B, 2009 influenza A/H1N1, and a 2009 influenza A/H1N1 RNA sequence mutation associated with oseltamivir resistance.

Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza A; influenza B; novel influenza A/H1N1; and a novel influenza A/H1N1 RNA sequence mutation associated with oseltamivir resistance

Devices and methods for diagnosis of susceptibility to diseases and disorders

Clinically intelligent diagnostic devices and methods

Growing community of inventors

Boston, MA, United States of America

Alice A Jacobs